Edwards Lifesciences files proposed sale notice

Edwards Lifesciences Corporation submitted a notice related to the proposed sale of securities.

Rhea-AI Filing Summary

Edwards Lifesciences Corporation submitted a notice related to the proposed sale of securities. The filing lists a Performance Stock Lapse of 1,359 shares with a 05/07/2023 date and a Restricted Stock Lapse of 141 shares with a 05/08/2023 date. The broker listed is Charles Schwab & Co., Inc.

Insights

Insider Transactions Specialist

Routine Form 144 notice listing recently lapsed equity items and a broker.

The filing records two equity lapse events: a Performance Stock Lapse of 1,359 shares dated 05/07/2023 and a Restricted Stock Lapse of 141 shares dated 05/08/2023

These entries are administrative disclosures of proposed sales; the filing does not state executed sales, proceeds, or timing for disposition. Subsequent regulatory filings would show whether sales occurred.

Key Figures

Performance Stock Lapse: 1,359 shares Restricted Stock Lapse: 141 shares Broker listed: Charles Schwab & Co., Inc.

3 metrics

Performance Stock Lapse 1,359 shares <date>05/07/2023</date>

Restricted Stock Lapse 141 shares <date>05/08/2023</date>

Broker listed Charles Schwab &amp; Co., Inc. Westlake, TX address shown

Key Terms

Performance Stock Lapse, Restricted Stock Lapse, Form 144

3 terms

Performance Stock Lapse financial

"Performance Stock Lapse | EDWARDS LIFESCIENCES CORPORATION | 1,359 | 05/07/2023"

Restricted Stock Lapse financial

"Restricted Stock Lapse | EDWARDS LIFESCIENCES CORPORATION | 141 | 05/08/2023"

Form 144 regulatory

"form_type: "144" in metadata and header lines referencing securities to be sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does Edwards Lifesciences (EW) Form 144 show?

The Form 144 lists a Performance Stock Lapse of 1,359 shares dated 05/07/2023 and a Restricted Stock Lapse of 141 shares dated 05/08/2023. It names Charles Schwab & Co., Inc. as the broker.

Does the Form 144 confirm the shares were sold?

No. The notice records a proposed sale-related disclosure for specified lapsed awards; it does not state that the shares were actually sold or report sale proceeds.

Who is the broker listed on the Form 144 for EW?

The filing names Charles Schwab & Co., Inc. at Westlake, TX as the broker associated with the notice; no further broker activity details are provided.

What dates are associated with the equity lapse events in the filing?

The filing shows the Performance Stock Lapse dated 05/07/2023 and the Restricted Stock Lapse dated 05/08/2023 as the recorded event dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001740963
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Edwards Lifesciences Corp
SEC File Number	001-15525
Address of Issuer	ONE EDWARDS WAY IRVINE CALIFORNIA 92614
Phone	9492502500
Name of Person for Whose Account the Securities are To Be Sold	Chopra Daveen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	1500	126905.00	575800000	05/22/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2023	Performance Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			1359	05/07/2023	Equity Compensation
Common	05/08/2023	Restricted Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			141	05/08/2023	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daveen Chopra
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)